{"nctId":"NCT02083107","briefTitle":"Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss","startDateStruct":{"date":"2013-02"},"conditions":["Postpartum Hemorrhage"],"count":636,"armGroups":[{"label":"sublingual misoprostol & rectal placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Misoprostol"]},{"label":"rectal & sublingual placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]},{"label":"rectal misoprostol & sublingual placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Misoprostol"]}],"interventions":[{"name":"Misoprostol","otherNames":["Misotac","Cytotec"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Patients booked for elective cesarean section.\n2. Singleton pregnancies. 3- Full term pregnancies (GA 37-42 weeks). 4- Patients with only previous one cesarian section\n\nExclusion Criteria:\n\n1. Primigravida.\n2. Blood dyscrasias.\n3. Large fibroids.\n4. Multiple pregnancies.\n5. Overdistended uterus eg. Hydramnios.\n6. Pre-eclampsia.\n7. Marked maternal anemia (Preoperative hemoglobin \\< 9 gm/dl).\n8. Previous history of PPH.\n9. Contraindications to prostaglandin therapy (e.g. history of severe bronchial asthma or allergy to misoprostol.\n10. Placenta previa.\n11. Contraindication to spinal anesthesia.\n12. Previous myomectomy.\n13. Previous two or more C.S.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"38 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Intraoperative Blood Loss","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"357.8","spread":"129.7"},{"groupId":"OG001","value":"641.7","spread":"135.7"},{"groupId":"OG002","value":"457.5","spread":"140.7"}]}]}]},{"type":"SECONDARY","title":"Need for Extra Ecbolics (Oxytocin).","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"209","spread":null},{"groupId":"OG001","value":"206","spread":null},{"groupId":"OG002","value":"204","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Hemoglobin Concentration","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.3","spread":"0.1"},{"groupId":"OG001","value":"-0.9","spread":"0.1"},{"groupId":"OG002","value":"-0.4","spread":"0.1"}]}]}]},{"type":"SECONDARY","title":"APGAR Score","description":"The Apgar score is the first test given to a newborn, it is referred to as an acronym for: Appearance, Pulse, Grimace, Activity, and Respiration. Scores obtainable are between 10 and 0, with 10 being the highest possible score. Pulse: above 100 beats per minute (2), below 100 beats per minute (1), absent (0). Respiration: Normal rate and effort, good cry (2), Slow or irregular,weak cry (1), absent (0). Grimace: Pulls away, sneezes, coughs, or cries with stimulation (2), Facial movement only (1), absent (0). Activity: Active, spontaneous movement (2), Arms and legs flexed with little movement (1), absent (0). Appearance: Normal color (2), Normal color (but hands and feet are bluish) (1), Bluish-gray or pale all over (0).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.5","spread":"0.5"},{"groupId":"OG001","value":"6.5","spread":"0.5"},{"groupId":"OG002","value":"6.5","spread":"0.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.5","spread":"0.5"},{"groupId":"OG001","value":"8.5","spread":"0.5"},{"groupId":"OG002","value":"8.5","spread":"0.5"}]}]}]},{"type":"SECONDARY","title":"Time to Resume Bowel Habits","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.1","spread":"3.1"},{"groupId":"OG001","value":"14.7","spread":"3.5"},{"groupId":"OG002","value":"14.5","spread":"3.5"}]}]}]},{"type":"SECONDARY","title":"Need for Extra Analgesics","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"62","spread":null},{"groupId":"OG002","value":"50","spread":null}]}]}]},{"type":"SECONDARY","title":"Need for Postoperative Blood Transfusion","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"10","spread":null},{"groupId":"OG002","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Wound Sepsis","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"5","spread":null},{"groupId":"OG002","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Adverse Effects","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"44","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42","spread":null},{"groupId":"OG001","value":"11","spread":null},{"groupId":"OG002","value":"24","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Change in Hematocrite Value","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.1","spread":"0.8"},{"groupId":"OG001","value":"-1.6","spread":"0.3"},{"groupId":"OG002","value":"-0.1","spread":"0.9"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":212},"commonTop":["Fever","Chills","wound sepsis"]}}}